Demetrios Kokkinopoulos

Title: Demetrios Kokkinopoulos: Innovator in Pharmaceutical Formulations

Introduction: Demetrios Kokkinopoulos, an accomplished inventor based in Kifissia, Greece, has made significant contributions to the field of pharmaceutical innovations. With two registered patents to his name, his work focuses on novel compositions aimed at treating tumors and leukemias.

Latest Patents: Kokkinopoulos's most recent patents revolve around pharmaceutical formulations that incorporate labdanes. These formulations utilize hydrated lipidic lamellar phases or liposomal compositions, which are created by combining various lipid molecules from synthetic and natural sources. Specifically, these compositions include one or more of the following: labd-13-ene-8α, 15-diol and its derivatives, labd-14-ene-8, 13-diol or its derivatives, 3β-hydroxy-labd-14-ene-8, 13-epoxy, and plant extracts containing the aforementioned labdanes. The compositions exhibit cytotoxicity against cancerous cells, making them a promising option for therapies targeting tumors and leukemias.

Career Highlights: Throughout his career, Demetrios Kokkinopoulos has had the opportunity to collaborate with notable companies such as P.N. Gerolymatos S.A. and Medexis S.A. His experience in these organizations has undoubtedly contributed to his innovative approaches in the pharmaceutical industry.

Collaborations: Among his collaborators are Thalia Anastassaki and Demetra Angelopoulou, both of whom have shared in the pursuit of advancing research and development in pharmaceutical formulations. Their teamwork has played a vital role in shaping Kokkinopoulos's inventions.

Conclusion: Demetrios Kokkinopoulos stands out as a prominent inventor whose work in pharmaceutical formulations demonstrates significant potential in cancer treatment. With a focus on labdane-based compositions, his innovations reflect the intersection of chemistry and medical science, ultimately aiming to improve outcomes for patients suffering from tumors and leukemias.